Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT03488134
Previous Study | Return to List | Next Study

Predicting Prognosis and Recurrence of Thyroid Cancer Via New Biomarkers, Urinary Exosomal Thyroglobulin and Galectin-3

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03488134
Recruitment Status : Active, not recruiting
First Posted : April 4, 2018
Last Update Posted : November 5, 2020
Sponsor:
Information provided by (Responsible Party):
National Taiwan University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : July 31, 2021
Estimated Study Completion Date : July 31, 2023